• HTG is Accelerating Precision Medicine

    From diagnosis to treatment, HTG is harnessing the power of transcriptome-wide profiling to drive translational research, clinical diagnostics and targeted therapeutics across a variety of disease areas.

    Learn More

  • HTG Transcriptome Panel Available Now

    Simplify gene expression analysis with our new comprehensive human transcriptome panel.

    Learn More

  • HTG Therapeutics

    Unlocking a differentiated  and disruptive approach to transformative drug discovery by leveraging proprietary RNA platform technologies to develop candidates with superior efficacy and safety profiles.

    LEARN MORE

 

HTG is a life science company advancing precision medicine by leveraging its innovative transcriptome-wide profiling technology to develop profiling diagnostics and novel drug candidates to determine the right therapy for the right patient.

News & Events

ESMO CONGRESS 2022

SEPTEMBER 9-13, 2022 | Join us at the European Society for Medical Oncology Congress in Paris, France

Posted on:

Keep Reading

The Festival of Genomics & Biodata 2023

January 25-26 | Come and see us in London at the 2023 Festival of Genomics

Posted on:

Keep Reading

Publication Highlights Potential Clinical Applications of the HTG Transcriptome Panel in Bladder Cancer

TUCSON, Ariz. , June 29, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced the customer publication of a peer reviewed journal article featuring…

Keep Reading

HTG to Sponsor Keynote Presentation Featuring Customer Use of its HTG EdgeSeq Technology in Clinical Trials

TUCSON, Ariz. , June 08, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it will be sponsoring a keynote presentation at the 7 th Annual…

Keep Reading

HTG Technology Featured in Multiple Scientific Abstracts Highlighting Novel Applications in Precision Medicine at ASCO 2022

TUCSON, Ariz. , June 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced its HTG EdgeSeq technology was highlighted in multiple…

Keep Reading

Publications

Read white papers or journal publications and view other scientific content. 

White Papers

Therapeutics

Posters

Abstracts

Peer Reviewed Publications

Editorials

Reviews


Careers at HTG

At HTG, we are always looking for talented individuals to help us deliver our next-generation sequencing-based products throughout the world.

New Careers

See All Careers


Page last updated May 05, 2022